Alopecia areata was more likely to develop in patients with inflammatory bowel disease (IBD) who were taking anti–tumor necrosis factor (TNF) therapy at the onset of the condition.

A new study published in the journal of Clinical and Experimental Dermatology showed that a strong topical corticosteroid ...